
January 4, 2023
RegMed Investors’ (RMi) pre-open: a dash of strength
January 3, 2023
RegMed Investors’ (RMi) pre-open: Expectation will be the word for 2023
December 30, 2022
RegMed Investors’ (RMi) pre-open: end it on a positive note and good-bye to 2022 sessions
December 29, 2022
RegMed Investors’ (RMi) pre-open: risk-on/risk-off sessions based on market’s insecurity, sector’s pricing uncertainty in an overcrowded universe
December 28, 2022
RegMed Investors’ (RMi) pre-open: a holiday shortened week
December 27, 2022
RegMed Investors’ (RMi) pre-open: roaming and ranging, not today
December 23, 2022
RegMed Investors’ (RMi) pre-open: awaiting the holiday and the Fed
December 22, 2022
RegMed Investors’ (RMi) pre-open: another shift to caution, there's still the risk that this is another trap to lure investors in just before a pullback
December 21, 2022
RegMed Investors’ (RMi) pre-open: a follow through for positive sector equities?
December 20, 2022
RegMed Investors’ (RMi) pre-open: time to cut further back on already reduced risk exposure
December 19, 2022
RegMed Investors’ (RMi) pre-open: a Santa Claus bounce after recent sell-off
December 16, 2022
RegMed Investors’ (RMi) pre-open finally Friday
December 15, 2022
RegMed Investors’ (RMi) pre-open: the cell and gene therapy sector suffered from indigestion post Jerome’s rate gospel
December 14, 2022
RegMed Investors’ (RMi) pre-open: waiting for Jerome’s latest interest rate hike decision
December 13, 2022
RegMed Investors’ (RMi) pre-open: been waiting to exhale - ha
December 12, 2022
RegMed Investors’ (RMi) pre-open: wait or take a risky shot at the oversold rolling up?
December 9, 2022
RegMed Investors’ (RMi) pre-open: December ain’t turning-out, so far to be a good month for the cell and gene therapy sector –up against resistance
December 8, 2022
RegMed Investors’ (RMi) pre-open: climbing the wall of worry
December 7, 2022
RegMed Investors’ (RMi) pre-open: shareholders have had a “rough ride” lately
December 6, 2022
RegMed Investors’ (RMi) pre-open: an uptrend after a share pricing purge
December 5, 2022
RegMed Investors’ (RMi) pre-open: looking for more as December begins
December 2, 2022
RegMed Investors’ (RMi) pre-open: jobs report looms as go markets and sector
December 1, 2022
RegMed Investors’ (RMi) pre-open: upside action, after a surge; there’s usually a purge
November 30, 2022
RegMed Investors’ (RMi) pre-open: forget Waiting for Godot, I’m waiting for Jerome
November 29, 2022
RegMed Investors’ (RMi) pre-open: post carnage, wishful thinking
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors